Biotech

All Articles

Takeda taps new head people oncology business-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of substantial management hirings, shootings ...

Vertex, hammered through AATD once more, goes down 2 possessions on throw away heap

.Vertex's attempt to treat an uncommon hereditary disease has struck another misfortune. The biotech...

Vir gains 3 T-cell engagers coming from Sanofi, gives up 25% of workers

.Vir Biotechnology's second-quarter earnings report wasn't short of significant updates. The company...

Galapagos stops CAR-T cell treatment trial over Parkinsonism case

.Galapagos has actually stopped briefly registration in a test of a BCMA-directed CAR-T tissue treat...

James Wilson leaving behind Penn to release 2 brand new biotechs

.After greater than 30 years, gene therapy pioneer James Wilson M.D., Ph.D., is actually leaving beh...

3 biotechs try to trump the summer months warm by losing workers

.As biotechs seek to switch a fresh webpage in August, at least 3 business have dropped personnel in...

venBio lifts $528M for fifth life sciences VC fund

.Veteran equity capital organization venBio has raised yet another half a billion dollars to buy bio...

Otsuka pays for $800M for Jnana as well as its own clinical-stage PKU medication

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Therapies for $800 million so the Eastern biot...

FibroGen gives up 75% of US team as possession flunks 2 additional tests

.FibroGen is actually substantially reorganizing its own organization, giving up 75% of its U.S. per...

Tracon winds down weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has chosen to relax functions weeks after an injectable immune system gate i...